Results 271 to 280 of about 9,502,534 (376)
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
What Is My Role? A Qualitative Study of Labor, Birth, and Postpartum Experiences of Partners. [PDF]
Pereda-Goikoetxea B +4 more
europepmc +1 more source
Pengembangan Alat Peraga Tekanan Hidrostatis Sebagai Media Pembelajaran Fisika SMA
Huda Hinggo Sapriki +2 more
openalex +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
Timing Routines With Patience: A Focused Ethnography on Newborn Breastfeeding in Hospitals. [PDF]
Frandsen AL +5 more
europepmc +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Applying Social Cognitive Theory to Understand Perspectives on Child Feeding Practices of Thai Female Caregivers With Young Children With Stunting. [PDF]
Vinitchagoon T +8 more
europepmc +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Diagnosing Breastfeeding Difficulties: Where Do We Stand? [PDF]
Galante L, Kobayashi E, Nishikawa M.
europepmc +1 more source

